English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
Science & Education
CML Science News
Clinical reality in CML is in constant change. Thanks to the hard work and progress of clinicians and researchers worldwide, interesting updates on CML science, diagnostics, treatment and care are regularly presented at international meetings and published in leading peer-reviewed journals.
This section provides you with a selection of scientific publications on CML, relevant news from scientific meetings and expert opinions from leaders in the field. You will also find links to active CML clinical trials.
CML publications
Please find below a selection of interesting articles on CML from peer-reviewed journals. Recent publications include:
Clinical CML papers
- Nilotinib versus dasatinib in achieving MR4.5 for de novo CML: The randomized JALSG CML212 study
Matsumura I et al. Blood Adv, Oct 2024 – open access publication - Tyrosine kinase inhibitor for CML: All the same?
Veltmaat L & Cortes J. Blood Adv, Oct 2024 – open access publication - Dose-escalation of second-line and first-line asciminib in chronic myeloid leukemia in chronic-phase: The ASC2ESCALATE Phase II trial
Atallah E et al. Future Oncol, Oct 2024 (epub ahead of print) – open access publication - Viral infections and incidence of reactivations in chronic myeloid leukemia patients
Addapt MD et al. Oncology, Oct 2024 (epub ahead of print) - Treatment-free remission after discontinuation of tyrosine kinase inhibitors in patients with chronic myeloid leukemia in the chronic phase: A systematic review and meta-analysis
Zheng Z et al. Discov Oncol, Oct 2024 – open access publication - Asciminib in advanced-line of treatment of CML
Shacham-Abdulafia A et al. Eur J Haematol, Oct 2024 (epub ahead of print) – open access publication - Intensification of upfront chemotherapy for patients with myeloid blast crisis in CML: A single centre experience
Lee BJ et al. Ann Hematol, Oct 2024 (epub ahead of print) – open access publication - Sudden blast crisis in a CML patient in treatment-free remission: A case report and literature review
Liang Q et al. Acta Haematol, Oct 2024 (epub ahead of print)
Scientific CML papers
- The BIM deletion polymorphism potentiates the survival of leukemia stem and progenitor cells and impairs response to targeted therapies
Yu M et al. Leukemia, Oct 2024 (epub ahead of print) - Computationally driven discovery of a BCR::ABL1 kinase inhibitor with activity in multi-drug resistant CML
Hill J et al. J Med Chem, Oct 2024 – open access publication
CML Congress Materials
European Hematology Association (EHA) 2024 Hybrid Congress
13-16 June, 2024 - Madrid
Click here to access the EHA Library and find oral presentations, e-Posters and abstracts on CML:
- Oral presentations - biology & translational research
- Oral presentations - clinical
- e-Posters - biology & translational research
- e-Posters - clinical
- Poster presentations - biology & translational research
- Poster presentations - clinical
- For publication only - biology & translational research
- For publication only - clinical
Ongoing clinical trials on CML
Search here for CML clinical trials:
Advances from key CML publications
This independent educational resource was provided over the last couple of months as a special service by the iCMLf in partnership with Springer Healthcare IME and is supported by a grant from Novartis Oncology.
Stories are based on articles published in international peer-reviewed journals, or conference sessions and written by highly experienced and knowledgeable writers.
You can access the CML stories from previous months here
